Edition:
India

Adverum Biotechnologies Provides 2019 Outlook


Monday, 7 Jan 2019 

Jan 6 (Reuters) - Adverum Biotechnologies Inc ::ADVERUM BIOTECHNOLOGIES PROVIDES 2019 OUTLOOK.ADVERUM BIOTECHNOLOGIES INC - ADVERUM'S CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $217.9 MILLION AS OF SEPTEMBER 30, 2018.ADVERUM BIOTECHNOLOGIES INC - ADVERUM EXPECTS THIS QUARTER-END CASH POSITION TO FUND OPERATIONS AT LEAST THROUGH FIRST HALF OF 2020.ADVERUM BIOTECHNOLOGIES INC - TO PROVIDE AN UPDATE ON ENROLLMENT FROM OPTIC PHASE 1 CLINICAL TRIAL IN FIRST HALF OF 2019.ADVERUM BIOTECHNOLOGIES INC - TO PROVIDE INTERIM DATA ON THREE COHORTS FROM OPTIC PHASE 1 CLINICAL TRIAL BY Q1 OF 2020.ADVERUM BIOTECHNOLOGIES INC - TO PROVIDE AN UPDATE ON RARE DISEASE PROGRAM'S PRECLINICAL DEVELOPMENT PLAN IN FIRST HALF OF 2019. 

Company Quote

6.09
0.8 +15.12%
14 Oct 2019